MARPE Nasal Floor Width:
Airway-Centric Expansion Logic
A Clinical Evidence Review
Should miniscrew-assisted rapid palatal expansion target nasal floor width as a primary outcome? Evidence and protocol guidance for skeletal expansion in adolescents and adults.
TL;DR MARPE nasal floor width expansion represents an emerging clinically relevant consideration in skeletal expansion therapy. Recent comparative studies demonstrate that MARPE achieves greater nasal floor width increase than conventional RPE, particularly in the molar region. However, nasal airway gains must be integrated into a broader skeletal expansion strategy rather than pursued as an isolated treatment goal.
Transverse maxillary deficiency affects both occlusal function and airway patency, yet most clinicians approach MARPE as a purely dental skeletal expansion protocol without explicit airway-centric measurement strategies. This article examines whether MARPE should deliberately target nasal floor width as a clinical outcome—drawing on current evidence and Dr. Mark Radzhabov's clinical observations from Orthodontist Mark's educational platform. The goal is to establish whether airway logic should inform MARPE treatment planning, load selection, and outcome assessment in both adolescent and adult patients.
What Is MARPE Nasal Floor Width Expansion?
nasal floor width
MARPE nasal floor width refers to the transverse dimension of the nasal floor and adjacent hard palate structures, measured at the level of the greater palatine foramina and molar region, which can expand when miniscrew-anchored devices apply direct palatal loading in skeletally mature and adolescent patients. Unlike conventional tooth-borne rapid palatal expanders (RPE), which rely on dental unit anchorage and produce primarily alveolar and dental changes, miniscrew-assisted expansion applies force directly to skeletal structures—the maxillary complex itself—rather than through tooth roots. This fundamental biomechanical difference allows clinicians to separate skeletal expansion from dental side effects, creating an opportunity to simultaneously address transverse deficiency while improving nasal floor and airway dimensions. The clinical rationale is straightforward: if MARPE produces greater skeletal expansion with less dental tipping, and if skeletal expansion inherently enlarges nasal floor width, then measuring and optimizing nasal floor gains becomes a legitimate treatment goal rather than an incidental finding. However, integrating airway-centric measurement into routine MARPE practice requires baseline assessment via cone-beam computed tomography (CBCT), clear anatomical landmarks, and recognition that nasal floor width gains do not automatically translate to improved airway function.
MARPE Versus Conventional RPE:
Skeletal Changes in Nasal Anatomy
A prospective randomized clinical trial comparing MARPE and conventional RPE in adolescent and young adult patients found meaningful differences in skeletal response, particularly in nasal floor dimensions. The study recruited 40 patients (14 men and 26 women) with transverse maxillary deficiency, randomly assigning them to either RPE (n=20, mean age 14.0±4.5 years) or MARPE (n=20, mean age 14.1±4.2 years) treatment groups. Both groups received identical expansion (35 turns) and underwent cone-beam CT imaging before treatment (T0), immediately after expansion (T1), and after a 3-month consolidation period (T2). The results demonstrated that MARPE achieved greater increases in nasal floor width at the molar region (M-NW) and at the greater palatine foramen (GPF) compared to RPE, both immediately after expansion and through consolidation. Additionally, MARPE produced greater bilateral maxillary width at the premolar and molar regions relative to RPE, while simultaneously reducing buccal displacement of anchor teeth—a critical advantage in avoiding undesired dentoalveolar effects. The frequency of midpalatal suture separation was 90% in the RPE group and 95% in the MARPE group, suggesting that both techniques effectively split the suture in this age range, but MARPE's skeletal vector directed force more efficiently into nasal floor expansion rather than dental movement. These findings provide the strongest current evidence that clinicians should measure nasal floor width as a discrete skeletal outcome in MARPE cases, particularly when treating patients with concurrent transverse maxillary and airway concerns.
Measuring Nasal Floor Width:
CBCT-Based Assessment and Monitoring
Routine baseline CBCT imaging in MARPE patients enables clinicians to establish discrete nasal floor width landmarks and track changes through treatment. The most reproducible measurements occur at two key anatomical sites: the molar region nasal floor width (M-NW), defined as the perpendicular distance between the nasal floor walls at the level of maxillary molar root apices, and the greater palatine foramen (GPF) separation distance, measured between the bilateral greater palatine foramina on the hard palate. In clinical practice, obtain axial CBCT slices at consistent coronal levels (typically 5–8 mm above the palatal mucosal surface) and use calibrated digital measurement tools to record baseline nasal floor dimensions bilaterally. This baseline becomes your treatment target: if a patient presents with a molar region nasal floor width of 32 mm at baseline, and comparative data suggest MARPE typically expands this dimension by 2.5–3.5 mm over 8–10 weeks of activation plus 3 months consolidation, you can set a realistic skeletal expansion goal (e.g., 35–36 mm post-treatment) and monitor progress via mid-treatment or immediate post-expansion imaging. Post-expansion CBCT should be obtained within 48–72 hours after completing activation turns to capture the maximum skeletal displacement before any rebound occurs, then again at 3 months consolidation to assess stability. Document nasal floor width changes alongside conventional skeletal landmarks (ANS separation, maxillary width at PM and M regions) to ensure MARPE is producing proportional expansion across all transverse dimensions rather than creating localized nasal floor gains at the expense of posterior maxillary width. This integrated approach—treating nasal floor width as a discrete but interconnected skeletal outcome—separates airway-centric MARPE practice from conventional approaches that measure only dental and palatal suture effects.
Identifying Candidates for Nasal Floor-Focused
MARPE Expansion
Not every MARPE patient requires explicit nasal floor width optimization as a primary goal. Clinician selection should prioritize airway-centric MARPE in patients presenting with concurrent transverse maxillary deficiency and documented airway narrowing—either via lateral cephalometric findings (decreased posterior airway space) or CBCT volumetric measurements (reduced nasal floor or palatal vault height). Adolescents with active palatal expansion potential (midpalatal suture imaging showing partial or incomplete fusion) are ideal candidates, as their sutures remain responsive to loading and MARPE can achieve substantial skeletal gains with minimal residual relapse. Young adults (ages 15–25) with individual variability in midpalatal suture maturation represent a second important cohort. Accurate suture staging via CBCT (Stages A through F maturation scales) helps determine whether conventional RPE remains viable or MARPE is necessary to overcome skeletal resistance. Avoid pursuing nasal floor width expansion in patients with primary alveolar (dental) crowding as the chief complaint unless radiographic assessment confirms that transverse maxillary skeletal deficiency is the underlying driver. Conversely, patients with sleep-disordered breathing, documented hypoxia events, or orthodontist-identified airway concerns benefit substantially from MARPE's capacity to enlarge nasal floor dimensions while simultaneously correcting malocclusion. Pretreatment airway evaluation—baseline CBCT volumetry, lateral cephalometric posterior airway space measurement, and sleep history screening—creates a clinical context in which nasal floor width becomes a trackable therapeutic target rather than an incidental measurement. Dr. Mark Radzhabov emphasizes in clinical education that combining airway assessment with skeletal expansion planning elevates MARPE from a device-centric approach to a patient-centered, multi-dimensional treatment strategy.
How MARPE Load Architecture Influences
Nasal Floor Expansion Patterns
The biomechanical principle underlying MARPE's nasal floor gains is direct miniscrew anchorage to the hard palate, allowing expansion force to be applied to the maxillary skeleton without traversing tooth roots or alveolar bone primarily. When activation turns are applied to a miniscrew-retained expander device such as the hybrid Hyrax or maxillary skeletal expander (MSE) systems, the expansion screw creates lateral vectors along the hard palatal midline, propagating force through the maxillary complex toward the lateral alveolar walls and, critically, toward the lateral nasal floor walls via the hard palate's lateral buttresses. This direct skeletal loading produces simultaneous transverse expansion of the maxillary body, the greater palatine canal region (encompassing the greater palatine foramen), and the nasal floor proper, whereas tooth-borne RPE concentrates lateral force at dental unit levels, producing primarily alveolar and dental displacement. The net result is that MARPE's skeletal vector inherently enlarges nasal floor width as part of the overall transverse maxillary expansion, rather than as a secondary or incidental effect. Activation protocols—typically 4 turns per day during the active expansion phase (8–10 weeks), followed by consolidation without activation for 3 months—allow the nasal floor to accommodate the imposed load gradually, reducing pain and adverse effects while promoting bone remodeling and resorption-deposition equilibrium at the expanded interface. The timing of post-activation consolidation is critical: during the first 3 months post-activation, nasal floor width gains continue to stabilize as bone density increases and suture neoformation occurs, meaning that final nasal floor width measurements should be obtained at 3-month or later consolidation intervals, not immediately post-activation. Clinicians who activate beyond the recommended 8–10 week window or exceed typical turn volumes risk creating excessive skeletal stress and potential bone dehiscence rather than proportional nasal floor expansion.
Common MARPE Errors in Nasal Floor-Focused
Treatment Planning
Several recurrent clinical mistakes undermine successful airway-informed MARPE practice. First, failing to obtain baseline CBCT or relying solely on occlusal models and lateral cephalograms eliminates the ability to measure nasal floor width at all—without volumetric imaging, clinicians cannot establish baseline dimensions, track mid-treatment progress, or validate post-treatment skeletal gains in nasal anatomy. Second, confusing dentoalveolar width changes with true skeletal nasal floor expansion: premolar and molar dentoalveolar widths (PM-MW, M-MW) increase in MARPE due to reduced buccal tooth tipping compared to RPE, but this reflects dental repositioning within the same alveolar envelope, not necessarily proportional nasal floor skeletal gain. Accurate nasal floor assessment requires measurements at the hard palate level (nasal floor proper and greater palatine foramen), not at alveolar crestal or dentoalveolar landmarks. Third, over-activating the MARPE screw in pursuit of maximal nasal floor expansion without monitoring cumulative skeletal displacement: activation protocols exceeding 8–10 weeks of consecutive turns or reaching more than 10–12 mm of screw expansion can produce excessive midpalatal bone stress, resulting in asymmetric expansion, localized bone necrosis, or delayed healing rather than proportional nasal floor growth. Fourth, neglecting to consolidate adequately before appliance removal and relapse prevention: clinicians who remove MARPE devices before 3 months post-activation may lose 10–20% of skeletal nasal floor gains as undercorrection occurs. Finally, selecting patients for MARPE without confirming midpalatal suture maturation status via CBCT staging: in fully fused adults, MARPE can still succeed in opening the suture via stress-induced bone remodeling, but requires explicit patient counseling regarding activation discomfort and slower skeletal response. Orthodontist Mark's clinical teaching emphasizes that baseline imaging assessment, realistic activation timelines, and post-consolidation verification imaging are non-negotiable components of evidence-based MARPE practice.
Beyond Anatomy: Linking MARPE Nasal Floor Width to
Airway Function
Increasing nasal floor width via MARPE creates anatomical space, but the clinical leap from skeletal gain to functional airway improvement requires cautious interpretation. Nasal floor width expansion is a necessary but not sufficient condition for improved airway patency; absolute gains in nasal floor dimensions must be integrated with other palatal and nasal anatomical factors—palatal vault height, nasal septum deviation, turbinate hypertrophy, and nasopharyngeal soft tissue configuration—to produce meaningful airway benefit. Current evidence demonstrates that MARPE produces measurable increases in nasal floor width at the molar region (M-NW) and greater palatine foramen (GPF) separations, and these skeletal gains correlate with modest improvements in transverse nasal diameter on axial CBCT sections. However, direct functional outcome data linking nasal floor width expansion to airway flow improvement, oxygen saturation changes, or resolution of sleep-disordered breathing symptoms remain limited in the orthodontic literature. Clinicians pursuing airway-informed MARPE should set realistic expectations: skeletal nasal floor expansion addresses only the transverse component of airway geometry. Anteroposterior airway space, velopharyngeal closure dynamics, and soft tissue tone depend on broader skeletal and muscular factors beyond MARPE's scope. Nevertheless, for patients with documented transverse maxillary and nasal floor narrowing contributing to airway compromise, MARPE can be a valuable component of a multi-disciplinary treatment plan that may include sleep medicine referral, nasal topical therapy, or subsequent orthognathic assessment. Measuring and optimizing nasal floor width in these patients represents a clinically pragmatic approach that aligns skeletal expansion outcomes with airway anatomy without overstating functional guarantees.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
How do I measure nasal floor width on CBCT for MARPE baseline assessment?
Obtain axial CBCT slices at 5–8 mm above palatal mucosal surface. Measure the perpendicular distance between lateral nasal floor walls at molar root level (M-NW) and between bilateral greater palatine foramina (GPF). Use calibrated digital measurement tools and record baseline bilaterally for comparison.
Does MARPE always expand nasal floor width more than RPE?
Current evidence shows MARPE achieves greater nasal floor width increases than RPE in the molar region and at the greater palatine foramen, particularly in adolescents and young adults. This advantage reflects direct skeletal anchorage versus tooth-borne mechanics.
What is the optimal activation protocol to maximize nasal floor skeletal gains without complications?
Standard MARPE activation is 4 turns per day for 8–10 weeks, followed by 3 months post-activation consolidation without further turning. Exceeding 10 weeks of consecutive activation or >10–12 mm total screw expansion risks excessive skeletal stress and asymmetric expansion.
When should I obtain post-expansion CBCT to assess nasal floor width changes?
Obtain CBCT within 48–72 hours after completing activation turns (immediate post-expansion) and again at 3 months post-activation consolidation. Three-month images capture final skeletal stabilization. Premature imaging may underestimate true gains.
Can MARPE nasal floor expansion alone improve sleep-disordered breathing?
MARPE increases nasal floor width, addressing the transverse airway component. However, functional airway improvement depends on broader nasal anatomy, anteroposterior space, and soft tissue factors. Treat nasal floor expansion as a structural contribution within multi-disciplinary airway assessment.
How do I distinguish dentoalveolar width changes from true skeletal nasal floor expansion in MARPE?
Measure at hard palate and nasal floor anatomical levels (M-NW, GPF), not alveolar crests. Dentoalveolar width (PM-MW, M-MW) reflects dental repositioning. Skeletal nasal floor width reflects bone-to-bone separation at palatal buttress regions.
What patient presentations indicate airway-informed MARPE as the treatment choice?
Adolescents or young adults with concurrent transverse maxillary deficiency and radiographic airway narrowing (reduced posterior airway space on lateral ceph. Narrow nasal floor on CBCT), particularly those with sleep history concerns or sleep medicine referral.
Is MARPE feasible in skeletally mature adults with fully fused midpalatal sutures?
Yes. MARPE can open fully fused sutures via stress-induced bone remodeling in adults, though skeletal response is slower and requires explicit activation timeline counseling. Suture maturation staging (Stages A–F) via CBCT guides realistic expectations.
What post-consolidation relapse should I anticipate in MARPE nasal floor width?
Evidence suggests MARPE skeletal gains are relatively stable through 3-month consolidation with appropriate retention. Premature appliance removal (before 3 months) or inadequate retention may result in 10–20% nasal floor width loss.
How does Orthodontist Mark recommend integrating airway assessment into routine MARPE patient screening?
Baseline CBCT with discrete nasal floor width measurement, lateral cephalometric posterior airway space assessment, and brief sleep history screening establish a multi-dimensional treatment context. This approach separates airway-centric MARPE from conventional device-focused protocols.
The evidence supports greater nasal floor width gains with MARPE compared to tooth-borne RPE, yet treating nasal floor width as a primary rather than secondary target requires careful patient selection and pre-treatment airway assessment. Clinicians should measure nasal floor dimensions via cone-beam CT at baseline, monitor changes through consolidation, and integrate findings into broader skeletal and functional outcomes. For detailed MARPE protocol guidance and case consultation, visit ortodontmark.com or explore Dr. Mark Radzhabov's clinical resources on miniscrew-assisted expansion technique.
